Biosketch / Results /

Manfred Hauben

Clinical Assistant Professor, Department of Medicine

Contact Info

212/573-1777
Manfred.Hauben@nyumc.org


Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP)
Hauben, Manfred; Aronson, Jeffrey K; Ferner, Robin E. Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP). Drug safety. 2016 May ;39(5):421-432 (1949622)

Revisiting the reported signal of acute pancreatitis with rasburicase: an object lesson in pharmacovigilance
Hauben, Manfred; Hung, Eric Y. Revisiting the reported signal of acute pancreatitis with rasburicase: an object lesson in pharmacovigilance. Therapeutic advances in drug safety. 2016 Jun;7(3):94-101 (2143262)

Bevacizumab-associated diverticulitis: results of disproportionality analysis
Hauben, Manfred; Hung, Eric. Bevacizumab-associated diverticulitis: results of disproportionality analysis. Expert review of clinical pharmacology. 2015 May ;8(3):271-272 (1556942)

Safety of Perflutren Ultrasound Contrast Agents: A Disproportionality Analysis of the US FAERS Database
Hauben, Manfred; Hung, Eric Y; Hanretta, Kelly C; Bangalore, Sripal; Snow, Vincenza. Safety of Perflutren Ultrasound Contrast Agents: A Disproportionality Analysis of the US FAERS Database. Drug safety. 2015 Nov ;38(11):1127-1139 (1709162)

Quantitative Signal Detection and Analysis in Pharmacovigilance
Bate, A; Pariente, A; Hauben, M; Béud, B. Quantitative Signal Detection and Analysis in Pharmacovigilance IN: Mann's Pharmacovigilance. Chichester, West Sussex, UK : John Wiley & Sons Inc., 2014 3rd ed.. p.331-354 (1606002)